Screening for kidney disease starts in pharmacy

Pharmacists are helping detect CKD sooner through point-of-care testing and risk assessment that connect at-risk patients with their GP. Chronic kidney disease (CKD) is a...

Verapamil for type 1 diabetes

Recent research has shed light on a potential new avenue to reduce insulin requirements for people with type 1 diabetes. An estimated 1.2 million Australians...

Long COVID: managing the after-effects

Some people who are infected with COVID-19 do not recover quickly. They live with the aftermath – long COVID – a multi-system condition that we must start learning how to manage, including pharmacists.

Beyond the pills: navigating depression and antidepressant use in older adults

Depression can significantly impact the lives of older Australians, carers and their families. Pharmacists offer valuable education and support, helping older patients understand the risks and benefits of their treatment and monitoring for adverse effects.

Motion sickness

Though typically short-lived, motion sickness can be distressing and disruptive.

Pharmacists welcome renewed focus on rural and regional health

Pharmacists have welcomed the renewed focus on rural and regional communities as Associate Professor Ruth Stewart takes up her role as Australia’s new National Rural Health Commissioner.